Document is current
Any future updates will be listed below
-
Authors
Tuyaerts, Sandra https://orcid.org/0000-0003-1255-8071
Van Nuffel, An M. T.
Naert, Eline
Van Dam, Peter A.
Vuylsteke, Peter
De Caluwé, Alex
Aspeslagh, Sandrine
Dirix, Piet
Lippens, Lien
De Jaeghere, Emiel
Amant, Frédéric
Vandecasteele, Katrien
Denys, Hannelore
-
Funding
Funding for this research was provided by:
Kom op tegen Kanker (not applicable)
Anticancer Fund (not applicable)
- License Information
-
More Information
Article History
Received: 8 March 2019
Accepted: 3 May 2019
First Online: 28 May 2019
Ethics approval and consent to participate
: This study obtained approval from the Belgian Federal Agency for Medicines and Health Products (FAHMP) and from the Ethics Committee of the Sponsor, Ghent University Hospital (UZ Ghent, reference number 2017/0304), the Ethics Committee of Universitair Ziekenhuis Antwerpen/Universiteit Antwerpen, the Ethics Committee of Institut Jules Bordet, Le Comité d’Ethique de Clinique et Maternité Sainte Elisabeth and Comité d’Ethique Hospitalo-Facultaire Saint-Luc – UCL. The study is conducted in accordance with the Helsinki Declaration, the International Conference of Harmonization Good Clinical Practice guidelines, and local regulatory requirements. Written informed consent will be obtained from each patient.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
